Coming November 4: ASH publishes its abstracts and its oral and poster sessions. We’ll add the institutions presenting them as they become publicly available.

Moderna at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Moderna brings 2 presentations to ASH 2026 in New Orleans. Its presence centres on how drug innovation is adapting to a changing regulatory landscape, framing a series of fireside chats on the subject. It is also part of the Back to Business Breakfast.

OrganizationASH 2026 Attendance
Moderna
Cambridge, MA
modernatx.com
Biotech
Biotechnology company developing mRNA medicines and vaccines.
Session
Back to Business Breakfast
Networking breakfast for hematology innovators and investors, introducing a new society platform for turning blood research into companies and products.
Talk
Session
Fireside Chats on Innovation in a Changing Regulatory Landscape
How FDA priorities, investor reactions to regulatory uncertainty, and new modeling tools shape the development of hematology discoveries into therapies.
New drugs
Talk

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Moderna

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction